DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Flupirtine is an investigational drug.
There have been 4 clinical trials for Flupirtine. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2007.
The most common disease conditions in clinical trials are Neoplasm Metastasis, Sclerosis, and Multiple Sclerosis, Relapsing-Remitting. The leading clinical trial sponsors are Haining Health-Coming Biotech Co., Ltd., University Medicine Greifswald, and AWD.pharma GmbH & Co. KG.
Recent Clinical Trials for Flupirtine
|Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor||Haining Health-Coming Biotech Co., Ltd.||Phase 2|
|Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo||Ludwig-Maximilians - University of Munich||Phase 1|
|Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine||AWD.pharma GmbH & Co. KG||Phase 1|